1 withdrawn. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Withdrawn 1 |
Follow Pre-diabetic: new trials by email Literature Review of Pre-diabetic trials Research Report on Pre-diabetic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Glucagon-like Peptide-1 Metabolism and Acute Neprilysin Inhibition Sacubitril/Valsartan 200mg (blinded), Valsartan 160mg (blinded) - Diabetes Mellitus, Type 2, Pre-diabetic | Phase 3 | Withdrawn | University of Pennsylvania | 2018-06-01 | 2026-09-21 |
Diabetes Mellitus, Type 2 (1) · Glucose Intolerance (1) · Hypertension (1)
Cardiovascular Diseases (1) · Diabetes Mellitus (1) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Hyperglycemia (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Vascular Diseases (1)
Valsartan (1) · sacubitril (1) · sacubitril and valsartan sodium hydrate drug combination (1)
University of Pennsylvania (1)
United States (1)